Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention
Paul K. Drain, Ashley R. Bardon, Jane M. Simoni, et al.
Current HIV/AIDS Reports (2020) Vol. 17, Iss. 5, pp. 487-498
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Technologies for HIV-1 drug resistance testing: inventory and needs
Karin J. Metzner
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 4, pp. 222-228
Open Access | Times Cited: 26
Real-Time Monitoring and Point-of-Care Testing: A Review of the Current Landscape of PrEP Adherence Monitoring
Alisse Hannaford, Yotam Arens, Helen Koenig
Patient Preference and Adherence (2021) Vol. Volume 15, pp. 259-269
Open Access | Times Cited: 30
Rapid Enzymatic Assay for Antiretroviral Drug Monitoring Using CRISPR-Cas12a-Enabled Readout
Maya A. Singh, Megan M. Chang, Qin Wang, et al.
ACS Synthetic Biology (2025)
Open Access
Validation of the REverSe TRanscrIptase Chain Termination assay for measuring tenofovir diphosphate in dried blood spots from a clinical pharmacokinetic trial
Benjamin P. Sullivan, Cosette Craig, Andrew T. Bender, et al.
Journal of Antimicrobial Chemotherapy (2025)
Closed Access
Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa
Ashley R. Bardon, Makhosazane Zondi, Jane M. Simoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention
Matthew A. Spinelli, Monica Gandhi
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 3, pp. 169-175
Closed Access | Times Cited: 2
Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
Jienchi Dorward, Richard Lessells, Katya Govender, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. 9
Open Access | Times Cited: 5
Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations
Ayokunle O. Olanrewaju, Benjamin P. Sullivan, Ashley R. Bardon, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes
Ashley R. Bardon, Jienchi Dorward, Yukteshwar Sookrajh, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e050116-e050116
Open Access | Times Cited: 11
Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
Xin Niu, Rachel W. Kubiak, Oraphan Siriprakaisil, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 8
REverSe TRanscrIptase chain termination (RESTRICT) for selective measurement of nucleotide analogs used in HIV care and prevention
Ayokunle O. Olanrewaju, Benjamin P. Sullivan, Alicia Gim, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
The ATEAM study: Advances in technology to enhance PrEP adherence monitoring (ATEAM) among young men who have sex with men
Jennifer Brothers, Sybil Hosek, Kody Keckler, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 12, pp. 2947-2957
Open Access | Times Cited: 6
Roadmap for Achieving Universal Antiretroviral Treatment
Simiso Sokhela, Samanta Tresha Lalla‐Edward, Mark J. Siedner, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 99-117
Open Access | Times Cited: 3
Brief Report: Transgender Women and Preexposure Prophylaxis Care: High Preexposure Prophylaxis Adherence in a Real-World Health Care Setting in New York City
Lila Starbuck, Sarit A. Golub, Augustus Klein, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2022) Vol. 90, Iss. 1, pp. 15-19
Open Access | Times Cited: 5
Perfil e adesão à terapia antirretroviral de pessoas vivendo com HIV/AIDS
Patrícia Paiva Carvalho, Sabrina Martins Barroso, Dalmo Correia, et al.
Revista Família Ciclos de Vida e Saúde no Contexto Social (2021) Vol. 10, Iss. 1, pp. 121-134
Open Access | Times Cited: 4
Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment
Cheríe Blair, Monica Gandhi, Steven Shoptaw, et al.
AIDS and Behavior (2022) Vol. 27, Iss. 6, pp. 1962-1971
Open Access | Times Cited: 3
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
Jienchi Dorward, Richard Lessells, Katya Govender, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Resiliência e adesão à terapia antirretroviral em pessoas vivendo com HIV: Revisão integrativa
Patrícia Paiva Carvalho, Lucas Rossato, Fábio Scorsolini-Comin
Ciencias Psicológicas (2023)
Open Access | Times Cited: 1
Strategies for Improving Adherence in Patients with HIVAIDS
Abubakar Yaro, Edmund Puca, Catherine O. Johnson
Journal of Biomedical Research & Environmental Sciences (2023) Vol. 4, Iss. 12, pp. 1675-1683
Open Access | Times Cited: 1
Quantification of Antiretroviral Drug Emtricitabine in Human Plasma by Surface Enhanced Raman Spectroscopy
M. Butler, Terry A. Jacot, Sucharita Dutta, et al.
ACS Omega (2024) Vol. 10, Iss. 5, pp. 4315-4325
Open Access
Rapid enzymatic assay for antiretroviral drug monitoring using CRISPR-Cas12a enabled readout
Maya A. Singh, Megan M. Chang, Qin Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pilot Evaluation of an Enzymatic Assay for Rapid Measurement of Antiretroviral Drug Concentrations
Ayokunle O. Olanrewaju, Benjamin P. Sullivan, Ashley R. Bardon, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 3
Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
Darryl Sokpa, Elizabeth Lyden, Nada Fadul, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 2
Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays
Richard E. Haaland, Amy Martin, Melkam Mengesha, et al.
AIDS Research and Human Retroviruses (2021) Vol. 37, Iss. 10, pp. 744-747
Open Access | Times Cited: 2
MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya
Joanne E. Mantell, Julie Franks, Allison Zerbe, et al.
BMJ Open (2022) Vol. 12, Iss. 11, pp. e064037-e064037
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top